| Literature DB >> 31466612 |
Marianne E Nellis1, Ruchika Goel2, Oliver Karam3.
Abstract
Pediatric oncology patients will likely require numerous transfusions of blood products, including red blood cell, platelet, and plasma transfusions, during the course of their treatment. Although strong evidence-based guidelines for these products in this patient population do not exist, given the morbidities associated with the receipt of blood products, practitioners should attempt to use restrictive transfusion strategies.Entities:
Keywords: Children; Oncology; Patient blood management; Transfusion
Mesh:
Year: 2019 PMID: 31466612 DOI: 10.1016/j.hoc.2019.05.011
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN: 0889-8588 Impact factor: 3.722